Vera Therapeutics Inc - Class A

NAS:VERA (USA)   Class A
$ 48.27 +0.13 (+0.27%) 09:36 AM EST
At Loss
P/B:
17.32
Volume:
7.04K
Avg Vol (2M):
1.47M
Volume:
7.04K
At Loss
Avg Vol (2M):
1.47M

Business Description

Vera Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US92337R1014

Share Class Description:

VERA: Class A
Description
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 5.42
Equity-to-Asset 0.7
Debt-to-Equity 0.24
Debt-to-EBITDA -0.3
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -6.1
3-Year EPS without NRI Growth Rate -5.1
3-Year FCF Growth Rate 0.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.97
9-Day RSI 70.96
14-Day RSI 73.61
6-1 Month Momentum % 68.51
12-1 Month Momentum % 305.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.97
Quick Ratio 6.97
Cash Ratio 6.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -89.6
Shareholder Yield % -5.42
Name Current Vs Industry Vs History
ROE % -85
ROA % -60.94
ROIC % -1397.02
ROC (Joel Greenblatt) % -2136.54
ROCE % -68.42

Financials (Next Earnings Date:2024-03-28 Est.)

VERA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VERA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vera Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.9
Beta 0
Volatility % 168.13
14-Day RSI 73.61
14-Day ATR ($) 2.937914
20-Day SMA ($) 42.8355
12-1 Month Momentum % 305.1
52-Week Range ($) 5.95 - 50.69
Shares Outstanding (Mil) 53.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vera Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Vera Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vera Therapeutics Inc Frequently Asked Questions

What is Vera Therapeutics Inc(VERA)'s stock price today?
The current price of VERA is $48.27. The 52 week high of VERA is $50.69 and 52 week low is $5.95.
When is next earnings date of Vera Therapeutics Inc(VERA)?
The next earnings date of Vera Therapeutics Inc(VERA) is 2024-03-28 Est..
Does Vera Therapeutics Inc(VERA) pay dividends? If so, how much?
Vera Therapeutics Inc(VERA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1